Literature DB >> 23766088

Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.

Shanmugam Muruganandan1, Helen J Dranse, Jillian L Rourke, Nichole M McMullen, Christopher J Sinal.   

Abstract

Bone is a dynamic tissue that is continuously remodeled through the action of formative osteoblasts and resorptive osteoclasts. Chemerin is a secreted protein that activates chemokine-like receptor 1 (CMKLR1), a G protein-coupled receptor expressed by various cell types including adipocytes, osteoblasts, mesenchymal stem cells (MSCs), and macrophages. Previously, we identified chemerin as a regulator of adipocyte and osteoblast differentiation of MSCs. Herein we examined the role of chemerin in Lin(-) Sca1(+) c-kit(+) CD34(+) hematopoietic stem cell (HSC) osteoclastogenesis. We found that HSCs expressed both chemerin and CMKLR1 mRNA and secreted chemerin protein into the extracellular media. Neutralization of chemerin with a blocking antibody beginning prior to inducing osteoclast differentiation resulted in a near complete loss of osteoclastogenesis as evidenced by reduced marker gene expression and matrix resorption. This effect was conserved in an independent model of RAW264.7 cell osteoclastogenesis. Reintroduction of chemerin by reversal of neutralization rescued osteoclast differentiation indicating that chemerin signaling is essential to permit HSC differentiation into osteoclasts but following blockade the cells maintained the potential to differentiate into osteoclasts. Mechanistically, neutralization of chemerin blunted the early receptor activator of nuclear factor-kappa B ligand induction of nuclear factor of activated T-cells 2 (NFAT2), Fos, Itgb3, and Src associated with preosteoclast formation. Consistent with a central role for NFAT2, induction or activation of NFAT2 by forced expression or stimulation of intracellular calcium release rescued the impairment of HSC osteoclastogenesis caused by chemerin neutralization. Taken together, these data support a novel autocrine/paracrine role for chemerin in regulating osteoclast differentiation of HSCs through modulating intracellular calcium and NFAT2 expression/activation. © AlphaMed Press.

Entities:  

Keywords:  Antibody; CMKLR1; Chemerin; Hematopoietic stem cell; NFAT2; Osteoclast

Mesh:

Substances:

Year:  2013        PMID: 23766088     DOI: 10.1002/stem.1450

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  28 in total

1.  Chemerin-induced arterial contraction is Gi- and calcium-dependent.

Authors:  David J Ferland; Emma S Darios; Richard R Neubig; Benita Sjögren; Nguyen Truong; Rosa Torres; Thomas S Dexheimer; Janice M Thompson; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2016-11-24       Impact factor: 5.773

Review 2.  Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.

Authors:  Sneha Soni; Meaghan Torvund; Chandi C Mandal
Journal:  Clin Exp Metastasis       Date:  2021-02-16       Impact factor: 5.150

Review 3.  Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events.

Authors:  Jiao Li; Lingyun Lu; Yi Liu; Xijie Yu
Journal:  J Mol Med (Berl)       Date:  2021-11-09       Impact factor: 4.599

Review 4.  Cistanche Deserticola for Regulation of Bone Metabolism: Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis.

Authors:  Cheng Wang; Feng Li; Yang Li; Hui Feng; Min-Wei Zhao; Peng-Fei Tu; Hua Tian
Journal:  Chin J Integr Med       Date:  2022-08-05       Impact factor: 2.626

5.  Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence.

Authors:  Abhishek Chandra; Anthony B Lagnado; Joshua N Farr; Megan Schleusner; David G Monroe; Dominik Saul; João F Passos; Sundeep Khosla; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2022-03-29       Impact factor: 6.390

6.  Chemokine-like receptor 1 deficiency leads to lower bone mass in male mice.

Authors:  Huashan Zhao; Dewen Yan; Liang Xiang; Chen Huang; Jian Li; Xiangfang Yu; Binbin Huang; Baobei Wang; Jie Chen; Tianxia Xiao; Pei-Gen Ren; Jian V Zhang
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

Review 7.  Bone Marrow Adipose Tissue and Skeletal Health.

Authors:  Shanmugam Muruganandan; Rajgopal Govindarajan; Christopher J Sinal
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

8.  Effect of weight loss on serum osteocalcin and its association with serum adipokines.

Authors:  Mohammed S Albadah; Hafedh Dekhil; Shaffi Ahamed Shaik; Mohammed A Alsaif; Mustafa Shogair; Shahid Nawaz; Assim A Alfadda
Journal:  Int J Endocrinol       Date:  2015-02-15       Impact factor: 3.257

Review 9.  Adipokines as potential prognostic biomarkers in patients with acute knee injury.

Authors:  Stefan Kluzek; Nigel K Arden; Julia Newton
Journal:  Biomarkers       Date:  2015-05-26       Impact factor: 2.658

10.  Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women.

Authors:  Liang Shi; Chaoming Mao; Xuefeng Wang; Rencong Liu; Lin Li; Xiao Mou; Ping Xu; Hongli Li; Chengcheng Xu; Guoyue Yuan; Bing Wan; Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.